Implantica

📣 We're thrilled to report that the article, "Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland," was published in the Journal of Medical Economics. Congratulations to each of the authors! Sam Harper York Health Economics Consortium York, UK Muralikrishnan Kartha, PhD Implantica Zug, Switzerland Stuart Mealing York Health Economics Consortium York, UK Dr. med. Yves M. Borbély Department of Visceral Surgery and Medicine, Inselspital Bern University Hospital Bern, Switzerland Prof. Dr. med. Joerg Zehetner Department of Visceral Surgery, swiss1chirurgie, Hirslanden Klinik Beau-Site Bern, Switzerland See the article: https://lnkd.in/g4Zt-cNA See the Press Release: https://lnkd.in/gQvrXjTG

📣 È emozionante vedere come il dottor Renzi e il team dell'ospedale Buon Consiglio Fatebenefratelli di Napoli abbiano abbracciato la nuova tecnologia RefluxStop™ per trattare i pazienti cronici con GERD. 🗞️ Ottieni la storia: https://lnkd.in/gUdyZzKv 📣 Exciting to see how Dr. Renzi and the team at Buon Consiglio Fatebenefratelli hospital in Naples have embraced the new technology of RefluxStop™ to treat chronic GERD patients. 🗞️ Get the story: https://lnkd.in/gUdyZzKv

Gastroesophageal Reflux Disease (GORD) has a serious economic impact in the UK, an estimated £55 of productivity per employee is lost every week due to GORD¹. Additionally, one study showed 9.5% of employee time is lost due to lower productivity while working known as presenteeism.¹ It's critical to treat GORD so employees and businesses stop losing valuable resources to the painful and relentless symptoms of GORD. See how Implantica's RefluxStop™ takes an innovative, new approach to the surgical treatment of GORD: https://lnkd.in/ei89DBiR

During Social Wellness Month we want to remind you: As as chronic illness, GERD can interrupt connections with friends and family, leaving patients feeling lonely.¹ Social Wellness Month is a great time to highlight this fact, it's another reason to encourage patients to keep looking for a GERD treatment that works. Learn about RefluxStop™, an innovative surgical treatment for GERD that does not encircle the food passageway thus making the benefits of a durable, surgical treatment for GERD available to more patients than previous traditional surgeries: https://lnkd.in/ei89DBiR 1. Katie Willard Virant, Psychology Today, February 15, 2022: https://lnkd.in/g29eaduf

Start your week off right and make your reservations for the American Foregut Society 2024 Annual Meeting today! The RefluxStop® Clinical Team will be there and we're excited to talk with you about the RefluxStop® procedure, the new surgical treatment that addresses the root cause of GERD by restoring the body's natural anatomy. We can't wait to connect with you in person but in the meantime, see more info on RefluxStop® at our Scientific Publications & Abstracts page: https://lnkd.in/gp3vGV3Y #AFS2024 #BetterTogether

A recent cost-effectiveness analysis from the perspective of the UK National Health Service determined that RefluxStop™ is likely to provide a net monetary benefit of £31,797 as compared to magnetic sphincter augmentation over a patient's lifetime.¹ Additionally, since RefluxStop™ does not encircle the food passageway, patients who are not candidates for traditional surgical options of the past could possibly be candidates for a durable surgical treatment for GORD with RefluxStop.™ Learn more at the Scientific Publications page: https://lnkd.in/gp3vGV3Y   *RefluxStop™ is not available for sale in the US and Canada. Contact Implantica for availability in your region. [email protected]

We were thrilled to see RefluxStop™ in this story in Medical Device Network of the first RefluxStop™ procedure completed with robotic surgery in the UK, at University Hospital Southampton NHS FT: https://lnkd.in/g_xksd_t

This abstract, based on a chart review of 79 RefluxStop® patients, was presented by Dr. med. Thorsten Lehmann as a poster at Digestive Disease Week® (DDW) 2024. Postoperatively, the mean GERD-HRQL (GERD-related quality of life) score significantly improved by 92.6% (p<.05). See the abstract: https://lnkd.in/gi_SSujQ

How bad can GERD get? This story from BBC News gives insights on the profoundly negative impact of GERD on a patient's life: https://lnkd.in/gjnXBzYu

About 14.5% of UK adults struggle with gastroesophageal reflux disease (GORD), it's very common and innovative treatments are urgently needed. RefluxStop™ offers a new surgical treatment that does not encircle the food passageway, now making a durable surgical treatment available to a whole new group of patients who were not candidates for traditional GORD surgery. Learn more about the RefluxStop™ procedure at our Scientific Publications and Abstracts page: https://lnkd.in/gp3vGV3Y